Doctor profile · Federal record

Dr. Jonathan Slusser, DO

Endocrinology, Diabetes & Metabolism Physician (CMS: Endocrinology) · Endocrinology, Diabetes & Metabolism Physician · Internal Medicine Physician · Doylestown, PA

  • NPI 1750644704
  • Accepts Medicare
  • 14 yrs in practice
  • Licensed in 2 states
  • Male
  • Solo practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
3900 Mechanicsville RD Ste 112
Doylestown, PA 189021669
(215) 645-7545
fax (215) 645-7546

Credentials & registration

NPPES · NUCC
NPI registered
June 2012 — 14 yrs on file
Profile last updated
October 21, 2025
Year of graduation
2012 — 14 yrs since
Specialty taxonomy
207RE0101X — NUCC code
State licenses (2)
Pennsylvania #OS019131 · New Jersey #25MB09686600
Medicaid
NJ #0534633

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1750644704. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
3,016
Distinct HCPCS
10
Medicare allowed
$139,256
HCPCS Description Services Patients Avg allowed
J0897 Injection, denosumab, 1 mg 2,160 27 $23
99214 Established patient office or other outpatient visit, 30-39 minutes 274 167 $132
95251 Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report 141 75 $35
99215 Established patient office or other outpatient visit, 40-54 minutes 120 72 $186
96372 Injection of drug or substance under skin or into muscle 66 31 $15
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes 66 38 $80
99213 Established patient office or other outpatient visit, 20-29 minutes 57 51 $92
99231 Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes 57 36 $50
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes 41 39 $131
99204 New patient office or other outpatient visit, 45-59 minutes 34 34 $172

In context: peer comparison

Among 5 peers in Doylestown Endocrinology, Diabetes & Metabolism Physician, average services per provider: 441. This provider delivers 6.8× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$283
Transactions
7
Manufacturers
4
Payer (manufacturer) Industry Txns Amount
Abbott Laboratories 4 $203.20
Tandem Diabetes Care, INC. 1 $41.15
Medtronic, INC. 1 $23.57
Amphastar Pharmaceuticals, INC. 1 $15.35

By nature of payment

Food and Beverage
$283

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,557
Patients
489
Total drug cost
$1,007,866
Drug Type Claims Patients Total cost
Levothyroxine Sodium Generic 215 67 $3,672
Jardiance (Empagliflozin) Brand 195 46 $232,379
Metformin Hcl Generic 143 52 $1,630
Ozempic (Semaglutide) Brand 118 33 $189,619
Metformin Hcl ER (Metformin Hcl) Brand 105 39 $3,272
Mounjaro (Tirzepatide) Brand 104 29 $244,595
Trulicity (Dulaglutide) Brand 87 21 $155,828
Glipizide Generic 85 31 $1,598
Farxiga (Dapagliflozin Propanediol) Brand 82 17 $97,664
Nano 2Nd Gen Pen Needle (Pen Needle, Diabetic) Brand 82 43 $10,095

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Jonathan Slusser's medical specialty?
Dr. Jonathan Slusser practices Endocrinology, Diabetes & Metabolism Physician in Doylestown, PA.
Where does Dr. Jonathan Slusser practice?
Dr. Jonathan Slusser practices at 3900 Mechanicsville RD Ste 112, Doylestown, PA 189021669. Office phone: 2156457545.
What is Dr. Jonathan Slusser's NPI?
Dr. Jonathan Slusser's National Provider Identifier (NPI) is 1750644704, issued by NPPES.
Does Dr. Jonathan Slusser accept Medicare assignment?
Yes. Dr. Jonathan Slusser accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Jonathan Slusser commonly perform?
Top Medicare-reported procedures in 2023: Injection, denosumab, 1 mg (HCPCS J0897); Established patient office or other outpatient visit (HCPCS 99214); Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report (HCPCS 95251). Source: CMS Medicare Physician & Other Practitioners file.